Intuitive Surgical stock falls 2.32 percent before Q3 report

Published on 10/04/2026 at 09:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

RBC analyst Kendall Au set a USD 575.00 target for Intuitive Surgical stock on October 1, 2026. Q2 revenue was USD 2.89 billion versus USD 2.44 billion a year earlier.

Pop-Art-Comicillustration mit Halbton-Punktmuster in Cyan, Magenta, Gelb und Schwarz, zeigt Chirurgen an Konsole mit dramatisch ausgefahrenen Roboterarmen, 1960er-Retro-Comicbuch-Ästhetik — Intuitive Surgical US46120E6023 Pop Art Comic zeigt futuristisches Roboterchirurgie Szenario in kräftigen Halbtontönen, Illustration mit AI erstellt.

Intuitive Surgical stock (ISIN US46120E6023) closed at USD 391.95 on Nasdaq on October 2, 2026, down 2.32 percent from USD 401.24. The next quarterly report is scheduled for October 20, 2026, according to MarketBeat.

Q2 revenue grew 18.4 percent

For the quarter ending June 30, 2026, Intuitive Surgical reported revenue of USD 2.89 billion and net profit of USD 818.1 million, according to Markets Insider. Revenue increased from USD 2.44 billion in the same quarter of 2025, while net profit rose from USD 658.4 million.

The 18.4 percent revenue comparison gives the stock a stronger operating backdrop than the October 2 price action alone suggests. The key question for the October report is whether procedure growth and new-system adoption can sustain that pace into the second half of 2026.

RBC sets USD 575.00 target

RBC Capital analyst Kendall Au maintained a Buy rating on October 1, 2026, and set a USD 575.00 price target, as Markets Insider reported. That target stands USD 183.05 above the October 2 closing price.

The market is also weighing execution risks. An earnings summary from Investing.com said US procedure growth slowed to 12 percent in Q2 2026 from 14 percent in Q1, while international growth reached 20 percent. Management maintained full-year da Vinci procedure growth guidance of 13.5 percent to 15.5 percent.

Stock stays below its yearly high

At USD 391.95, the shares remained below the Nasdaq session high of USD 406.47 and within a 52-week range of USD 328.57 to USD 603.88 on October 2, 2026. Intuitive Surgical's market capitalization was USD 138.5 billion on that date, keeping valuation and execution central to the upcoming earnings debate.